GAIN THERAPEUTICS, INC Restricted Cash
GAIN THERAPEUTICS, INC (GANX) had Restricted Cash of $35.59 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets
us-gaap:RestrictedCash · last filed 2026-08-11
- 2026-06-30: Restricted Cash $35.59K.
- 2026-03-31: Restricted Cash $36.09K.
- 2025-12-31: Restricted Cash $36.30K.
- 2025-09-30: Restricted Cash $36.12K.
| Period end | Restricted Cash |
|---|---|
| 2026-06-30 | $35.59K 10-Q · filed 2026-08-11 |
| 2026-03-31 | $36.09K 10-Q · filed 2026-05-11 |
| 2025-12-31 | $36.30K 10-Q · filed 2026-08-11 |
| 2025-09-30 | $36.12K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $36.28K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $32.54K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $31.70K 10-K · filed 2026-03-26 |
| 2024-09-30 | $33.87K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $31.80K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $31.74K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $34.02K 10-K · filed 2025-03-27 |
| 2023-09-30 | $31.14K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $31.82K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $31.12K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $30.82K 10-K · filed 2024-03-26 |
| 2022-09-30 | $28.86K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $29.84K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $30.86K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $31.28K 10-K · filed 2023-03-23 |
| 2021-09-30 | $30.87K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $42.07K 10-Q · filed 2021-08-12 |
| 2020-12-31 | $11.37K 10-K · filed 2022-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B |